Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women

American Journal of Epidemiology

Volumn 153, Issue 2, 2001, Pages 145-152

  Rodriguez, Carmen ^a   Calle, Eugenia E ^a   Patel, Alpa V ^a   Tatham, Lilith M ^a,b   Jacobs, Eric J ^a   Thun, Michael J ^a,b  

^a AMERICAN CANCER SOCIETY   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Body mass index; Cardiovascular diseases; Estrogen replacement therapy; Mortality

Indexed keywords

ESTROGEN;

ADULT; AGED; AGING; ARTICLE; BODY MASS; BREAST CANCER; CANCER MORTALITY; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORTALITY; POSTMENOPAUSE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STROKE;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASMS; OBESITY; PATIENT SELECTION; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 0035863903     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/153.2.145     Document Type: Article

References (31)

1. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community
2. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women
3. Noncontraceptive estrogens and mortality: Long-term follow-up of women in the Walnut Creek Study
4. Mortality in a cohort of long-term users of hormone replacement therapy: An updated analysis
5. Decreased mortality in users of estrogen replacement therapy
6. Cause-specific mortality in women receiving hormone replacement therapy
7. Postmenopausal hormone therapy and mortality
8. Reduced mortality associated with long-term postmenopausal estrogen therapy
9. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
10. The use of estrogens and progestins and the risk of breast cancer in post-menopausal women
11. Prior to use of estrogen replacement therapy, are users healthier than nonusers?
12. Cardioprotective effect of hormone replacement therapy in postmenopausal women: Is the evidence biased?
13. Hormone replacement therapy: The need for reconsideration
14. Selection, follow-up, and analysis in the American Cancer Society prospective studies
15. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants
16. Risk factors for fatal colon cancer in a large prospective study
17. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States
18. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women
19. Hormone replacement therapy and colorectal cancer: Interpreting the evidence
20. Estrogen replacement therapy and fatal ovarian cancer
21. Obesity, atherosclerosis, and coronary artery disease
22. Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status
23. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
24. The role of hormone replacement therapy in the risk of breast cancer and total mortality in women with a family history of breast cancer
25. Hormone replacement therapy and biological aggressiveness of breast cancer
26. Survival in women receiving hormone replacement therapy. A record-linkage study of a large population-based cohort
27. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
28. Design of the Women's Health Initiative clinical trial and observational study